Evidence map›Paper›PMID 31484735›Full record

Trial reportJournal of immunology (Baltimore, Md. : 1950)2019

T Cell- and Monocyte-Specific RNA-Sequencing Analysis in Septic and Nonseptic Critically Ill Patients and in Patients with Cancer.

Michael L Washburn, Zhang Wang, Andrew H Walton, S Peter Goedegebuure, David J Figueroa, Stephanie Van Horn, Julie Grossman, Katja Remlinger, Heather Madsen, James Brown and 7 more

Abstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Journal of immunology (Baltimore, Md. : 1950), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Cancer and sepsis.Clinical science (London, England : 1979) · 2023
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Michael L WashburnPharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426; michael.l.washburn@gsk.com hotch@wustl.edu.ORCID 0000-0002-9497-2163
Zhang WangPharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426.
Andrew H WaltonDepartment of Anesthesiology, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110.
S Peter GoedegebuureDepartment of Surgery, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110.
David J FigueroaPharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426.
Stephanie Van HornPharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426.ORCID 0000-0002-6760-7953
Julie GrossmanDepartment of Surgery, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110.ORCID 0000-0001-9323-5228
Katja RemlingerPharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426.
Heather MadsenPharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426.
James BrownPharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426.ORCID 0000-0002-9368-627X
Roopa SrinivasanPharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426.
Amaya I WolfPharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426.ORCID 0000-0002-8798-4203
Scott B BergerPharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426.
Victoria N YiDepartment of Anesthesiology, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110.ORCID 0000-0002-3385-5430
William G HawkinsDepartment of Surgery, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110.ORCID 0000-0001-7087-3585
Ryan C FieldsDepartment of Surgery, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110.
Richard S HotchkissDepartment of Anesthesiology, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110; michael.l.washburn@gsk.com hotch@wustl.edu.

Funding

Washington University SPORE in Pancreatic CancerP50CA196510 · NCI · WASHINGTON UNIVERSITY · PI HAWKINS, WILLIAM G · 2016 to 2020
$10.9M
Enhancing Innate and Adaptive Immunity to Improve Sepsis SurvivalR35GM126928 · NIGMS · WASHINGTON UNIVERSITY · PI Richard Samuel Hotchkiss · 2018 to 2026
$4.7M
NCI NIH HHS P50 CA196510NIGMS NIH HHS R35 GM126928
6 · The paper itself

Abstract

Sepsis is characterized as life-threatening organ dysfunction caused by a dysregulated host immune response to infection. The purpose of this investigation was to determine the differential effect of sepsis on innate versus adaptive immunity, in humans, by examining RNA expression in specific immune cell subsets, including monocytes/macrophages and CD4 and CD8 T cells. A second aim was to determine immunosuppressive mechanisms operative in sepsis that might be amenable to immunotherapy. Finally, we examined RNA expression in peripheral cells from critically ill nonseptic patients and from cancer patients to compare the unique immune response in these disorders with that occurring in sepsis. Monocytes, CD4 T cells, and CD8 T cells from septic patients, critically ill nonseptic patients, patients with metastatic colon cancer, and healthy controls were analyzed by RNA sequencing. Sepsis induced a marked phenotypic shift toward downregulation of multiple immune response pathways in monocytes suggesting that impaired innate immunity may be fundamental to the immunosuppression that characterizes the disorder. In the sepsis cohort, there was a much more pronounced effect on gene transcription in CD4 T cells than in CD8 T cells. Potential mediators of sepsis-induced immunosuppression included

Indexed as

Sequence Analysis, RNAAdultAgedCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCritical IllnessFemaleGene Expression Regulation, NeoplasticHumansImmune ToleranceMaleMiddle AgedMonocytesNeoplasm ProteinsNeoplasmsProspective StudiesNeoplasm ProteinsRNA, Neoplasm

Identifiers

PMID31484735
PMCPMC6761013

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.